AMA statement on Medicare cuts

Translate to Spanish or other 102 languages!

The AMA is extremely disappointed and dismayed that Congress failed to prevent Medicare cuts next year, threatening the financial viability of physician practices and endangering access to care for Medicare beneficiaries.Image for illustration purposes
The AMA is extremely disappointed and dismayed that Congress failed to prevent Medicare cuts next year, threatening the financial viability of physician practices and endangering access to care for Medicare beneficiaries.Image for illustration purposes

Mega Doctor News

- Advertisement -

The following statement is attributable to:

  

Jack Resneck Jr., M.D.
President, American Medical Association  

- Advertisement -

The AMA is extremely disappointed and dismayed that Congress failed to prevent Medicare cuts next year, threatening the financial viability of physician practices and endangering access to care for Medicare beneficiaries. This 2% cut following two decades of flat payment rates will have consequences on health care access for older Americans. High inflation compounds the threat to practice viability because physicians are the only Medicare providers without annual inflation-based updates. We are deeply worried that many practices will be forced to stop taking new Medicare patients – at a time when access to care is already inadequate. Congress must immediately begin the work of long-overdue Medicare physician payment reform that will lead to the program stability that beneficiaries and physicians need.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

The Rio Grande Valley Makes Its Voice Heard

 Voter participation increased substantially across four Rio Grande Valley counties during the November 3, 2026, general election, according to preliminary figures released by the Advocacy Alliance Center of Texas (AACT NOW), a nonprofit organization promoting nonpartisan civic engagement.

STHS Heart Ranked Among Texas’ Top 5 Hospitals for Coronary Intervention

For Valley residents, STHS Heart continues to distinguish itself through nationally recognized heart and vascular services and a commitment to delivering high-quality, compassionate care close to home.
- Advertisement -